Stock info Addex Therapeutics | Filter Basic-Info
Stock: Addex Therapeutics (Swiss small caps), ISIN: CH0029850754
| Last Price | 0.19 | Max Price | 0.21 |
| Min Price | 0.04 | 1 Year return | 90.00 |
| Sector | Health Care | Subsector | Biotechnology |
| Annual report 2014 |
Sector Review Addex Therapeutics
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 3 | 141,925 | 0.00 % |
| 2020 | 4 | 170,231 | 0.00 % |
| 2021 | 3 | 252,886 | 0.00 % |
| 2022 | 1 | 238,500 | 0.00 % |
| 2023 | 0 | 0 | 0.00 % |
Advice Addex Therapeutics
No Records Found
News Addex Therapeutics
No Records Found
Annual reports Addex Therapeutics
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Addex Therapeutics
Addex Therapeutics
(CH0029850754)Addex Therapeutics's revenues between 2011 and 2015 were far from constant and moved between 0,12 million CHFF and 0,79 million CHFF. Addex Therapeutics's net results between 2011 and 2015 were very fluctuating and moved between -31,14 million CHFF and -2,98 million CHFF.
Between 2006 and 2016 the global biotech companies gained around 59 percent. As from 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.
The Swiss company didn't pay out any dividends (in the past 5 years).
Addex Therapeutics had about 210 employees at the end of 2015.
Addex Therapeutics' balance mostly financed with equity
At the end of 2015 the Swiss company's balance sheet was worth 2,89 million CHFF. Last year the total debt of the company was 1,23 million CHFF. This equals around 42,56 percent of the total balance sheet. The Swiss company's price/earnings-ratio was -9. So the market valued the stock at -9 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.
At the end of 2015 the biotech company's market capitalization (the number of shares times the market price) equaled around 33,21 million CHFF. At the end of 2015 the Swiss company had around 10,85 million stocks listed on the stock exchange(s).
All Addex Therapeutics's annual reports can be found here. More information about Addex Therapeutics can be found it's website. .
Results Addex Therapeutics
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
0
|
0
|
1
|
7
|
3
|
4
|
| Costs |
5
|
4
|
4
|
8
|
18
|
17
|
| Profit |
-4
|
-3
|
-3
|
-2
|
-15
|
-13
|
| Margin of profit |
-1076.92
|
-787.50
|
-656.00
|
-24.48
|
-522.26
|
-331.44
|
| ROI |
-253.01
|
-1431.82
|
-244.78
|
-4.18
|
-57.92
|
-88.02
|
Balance Addex Therapeutics
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
2
|
0
|
1
|
39
|
26
|
15
|
| Debt |
1
|
1
|
2
|
3
|
8
|
6
|
| Total assets |
3
|
2
|
3
|
42
|
33
|
20
|
| Solvency |
57.44
|
13.10
|
43.79
|
92.96
|
77.26
|
72.40
|
| Cash |
3
|
1
|
3
|
42
|
32
|
19
|
| Cashflow |
-3
|
-3
|
-2
|
2
|
-9
|
-12
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
-2.14
|
-1.84
|
-1.24
|
0.59
|
-1.26
|
-2.19
|
Details Addex Therapeutics
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
2.85
|
1.84
|
2.29
|
2.25
|
1.64
|
| Eps |
-0.28
|
-0.25
|
-0.07
|
-0.56
|
-0.48
|
| Price/earnings-ratio |
-10.18
|
-7.36
|
-32.71
|
-4.02
|
-0.40
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.02
|
0.10
|
1.49
|
0.96
|
0.54
|
| Market to book |
0.01
|
0.05
|
0.65
|
0.43
|
2.84
|
| Cashflow per stock |
-0.23
|
-0.16
|
0.07
|
-0.36
|
-0.45
|
| Stocks |
12
|
13
|
26
|
27
|
27
|
| Market Cap |
32.96
|
24.69
|
60.47
|
59.86
|
5.15
|
Dividend Addex Therapeutics
Price info Addex Therapeutics
|
Date
|
Price
|
|---|---|
|
22 Apr 2024
|
0.19
|
|
18 Apr 2024
|
0.19
|
|
17 Apr 2024
|
0.18
|
|
09 Apr 2024
|
0.21
|
|
05 Apr 2024
|
0.13
|
|
03 Apr 2024
|
0.10
|
|
30 Mar 2024
|
0.10
|
|
22 Mar 2024
|
0.09
|
|
18 Mar 2024
|
0.08
|
|
15 Mar 2024
|
0.08
|
|
12 Mar 2024
|
0.08
|
|
11 Mar 2024
|
0.07
|
|
09 Mar 2024
|
0.07
|
|
07 Mar 2024
|
0.07
|
|
01 Mar 2024
|
0.06
|
|
29 Feb 2024
|
0.07
|
|
27 Feb 2024
|
0.07
|
|
22 Feb 2024
|
0.07
|
|
21 Feb 2024
|
0.07
|
|
20 Feb 2024
|
0.07
|
|
15 Feb 2024
|
0.07
|
|
14 Feb 2024
|
0.08
|
|
13 Feb 2024
|
0.07
|
|
09 Feb 2024
|
0.07
|
|
08 Feb 2024
|
0.07
|
|
07 Feb 2024
|
0.08
|
|
06 Feb 2024
|
0.08
|
|
05 Feb 2024
|
0.07
|
|
01 Feb 2024
|
0.07
|
|
31 Jan 2024
|
0.07
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
